De Candia, Erica
 Distribuzione geografica
Continente #
NA - Nord America 1.805
EU - Europa 1.782
AS - Asia 396
OC - Oceania 13
SA - Sud America 12
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.020
Nazione #
US - Stati Uniti d'America 1.786
SE - Svezia 365
PL - Polonia 363
DE - Germania 323
IT - Italia 227
CN - Cina 203
UA - Ucraina 135
IE - Irlanda 111
FR - Francia 90
GB - Regno Unito 66
IN - India 54
SG - Singapore 36
FI - Finlandia 31
IR - Iran 18
TR - Turchia 18
BE - Belgio 16
JP - Giappone 14
HK - Hong Kong 13
AU - Australia 12
HU - Ungheria 11
BR - Brasile 10
MX - Messico 10
CA - Canada 8
NL - Olanda 7
VN - Vietnam 7
AT - Austria 6
MY - Malesia 6
RO - Romania 6
CH - Svizzera 5
IL - Israele 5
RU - Federazione Russa 5
ES - Italia 4
MK - Macedonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
EG - Egitto 3
ID - Indonesia 3
PK - Pakistan 3
IQ - Iraq 2
JO - Giordania 2
KR - Corea 2
MN - Mongolia 2
PH - Filippine 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BZ - Belize 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 4.020
Città #
Warsaw 361
Chandler 333
Ashburn 134
Dublin 106
Fairfield 106
San Mateo 90
Wilmington 83
Jacksonville 66
Woodbridge 62
Ann Arbor 59
Nanjing 54
Houston 45
Seattle 45
Boston 43
Marseille 42
Princeton 36
Rome 36
Boardman 34
Dearborn 33
New York 32
Beijing 30
Cambridge 28
Cattolica 28
Milan 28
Redwood City 28
Singapore 24
Lawrence 20
Nanchang 18
Los Angeles 16
Brussels 13
Redmond 13
Andover 12
Augusta 12
Hangzhou 12
Hong Kong 12
Nürnberg 12
Pune 12
Izmir 11
Norwalk 11
Bremen 10
Budapest 10
Chicago 10
London 10
Mountain View 10
San Diego 10
Zhengzhou 10
Hebei 8
Kunming 7
Shenyang 7
University Park 7
Washington 7
Bari 6
Cuauhtémoc 6
Kish 6
Putrajaya 6
San Jose 6
Ypsilanti 6
Changsha 5
Dong Ket 5
Florence 5
Kocaeli 5
Sydney 5
Busto Arsizio 4
Hefei 4
Leawood 4
Perugia 4
Prilep 4
Tustin 4
Abidjan 3
Acton 3
Bonn 3
Brisbane 3
Buffalo 3
Castelnuovo Rangone 3
Detroit 3
Esslingen am Neckar 3
Genzano Di Roma 3
Guangzhou 3
Hadera 3
Hyderabad 3
Jakarta 3
Jiaxing 3
Jinan 3
Menlo Park 3
Monza 3
Ottawa 3
San Cesareo 3
Shanghai 3
Southend 3
São Paulo 3
Timisoara 3
Tokyo 3
Vienna 3
Amersham 2
Ardabil 2
Bengaluru 2
Bern 2
Bochum 2
Bologna 2
Brighton 2
Totale 2.420
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 276
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 219
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 147
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 127
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 125
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 125
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 122
Data on the application of early coagulation support protocol in the management of major trauma patients 111
Effect of fibrinogen concentration on the velocity of platelet aggregation. 102
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 86
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 81
Functional role of protease activated receptors in vascular biology 79
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 78
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 77
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 76
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 75
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 73
Mechanisms of platelet activation by thrombin: a short history 70
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 69
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 68
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 68
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 67
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 66
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 66
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 65
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 63
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 63
Hemophilia A and von Willebrand deficiency: therapeutic implications 62
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 62
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 61
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 60
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 60
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 58
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 57
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 57
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 53
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 52
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 51
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 50
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 50
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 49
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 48
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 48
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 48
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 48
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 45
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 44
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 43
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 43
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 42
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 42
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 38
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 36
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 33
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 24
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 20
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 19
Extended coagulation profile of children with Long Covid: a prospective study 17
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 16
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 15
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 4
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 4
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 4
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 2
Totale 4.109
Categoria #
all - tutte 16.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 0 19
2019/2020623 77 21 29 31 20 55 88 29 52 36 104 81
2020/2021579 29 68 12 64 70 73 46 21 50 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024529 19 161 27 34 28 70 48 16 12 26 52 36
Totale 4.109